Skip to main content

Table 2 Performance of risk models for predicting 5 year risk of T2D in men

From: Predictive value of serum testosterone for type 2 diabetes risk assessment in men

 

Incidence (n/N)

AROC (95 % CI)

HL Chi-SQ statistic

P for HL

AIC

BIC

Risk prediction models: variables

 Model 1: Variables from AUSDRISK a

147/1655

0.76 (0.72,0.80)

5.29

0.726

895

960

 Model 2: Model 1 with variables from other risk models b

147/1655

0.82 (0.79,0.86)

4.84

0.775

847

987

 Model 3: Model 2 with total testosterone (continuous variable)

147/1655

0.82 (0.79,0.86)

4.45

0.815

844

990

 Model 4: Model 2 with total testosterone (<16 vs ≥16 nmol/L)

147/1655

0.83 (0.79,0.86)

3.97

0.860

846

992

 Model 5: Backwards selection modelc

147/1655

0.82 (0.78,0.85)

5.43

0.711

825

885

Sensitivity analyses

      

 Model 6: Model 4 without imputation (15.5 % missing)

126/1399

0.82 (0.78,0.86)

NA

NA

NA

NA

 Model 7: Model 4 for NWAHS cohort

62/820

0.79 (0.74,0.85)

NA

NA

NA

NA

 Model 8: Model 4 for FAMAS cohort

85/835

0.84 (0.79,0.88)

NA

NA

NA

NA

  1. Notes: AROC area under receiver operating characteristic curve (imputation with median AROC reported), HL Hosmer-Lemeshow, AIC Akaike information criterion; Bayesian information criterion, NA not applicable because we are not fitting a new model - just testing the existing model; a Age, ethnicity/country of birth, family history of diabetes, IFG instead of self reported high blood glucose, currently taking blood pressure medications, current smoking status, physical inactivity, waist circumference category; b Pre-diabetes, BMI category, diagnosed cardiovascular disease, high blood pressure, high triglycerides, low HDL-C, income category; c Backwards selection model started with all available variables included in Model 4, dropped if p > 0.25, re-entered if p < 0.20 (retained variables were family history of diabetes, currently taking blood pressure medications, current smoking, waist circumference category, pre-diabetes, high blood pressure, low HDL-C low serum testosterone <16 nmol/L); Net changes in AROC were: Model 5 vs Model 2, 0.0093 (95 % CI: −0.0032,0.0218, P = 0.1455)